Log in to save to my catalogue
Log in to save to my catalogue

Correction: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian po...

| Ask | Become a Library member

Correction: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian po...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_87e81b0310304455b1cd061191310410

Correction: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial

About this item

Full title

Correction: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial

Author / Creator

Chevret, Sylvie , Bouadma, Lila , Dupuis, Claire , Burdet, Charles , Timsit, Jean‑Francois and the COVIDICUS RCT group

Publisher

Cham: Springer International Publishing

Journal title

Annals of Intensive Care, 2023-09, Vol.13 (1), p.95-1, Article 95

Language

English

Formats

Articles

Publication information

Publisher

Cham: Springer International Publishing

Subjects

More information

Alternative Titles

Full title

Correction: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_87e81b0310304455b1cd061191310410

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_87e81b0310304455b1cd061191310410

Other Identifiers

ISSN

2110-5820

E-ISSN

2110-5820

DOI

10.1186/s13613-023-01194-x

How to access this item

Log in as a Library member

Full text available

View in old catalogue

Connecting people and collections